Hyloris Gets Head Start On Maxigesic IV In US

FDA Sets Earlier Than Expected PDUFA Date For Value-Added Intravenous Analgesic

 
• By Chloe Kent
June 2022 calendar
Hyloris has been granted a June 2022 PDUFA date • Source: Alamy

More from Value Added Medicines

More from Products